P W Armstrong|B D Colen - JoVE Visualize

Showing results (131-140 of 210) with videos related to

Pageof 21

Sort By:

The Canadian Journal of Cardiology|September 1, 1992

Reverse redistribution on exercise thallium scintigraphy: relationship to coronary patency and ventricular function after myocardial infarctionA Langer, R J Burns, M R Freeman, et al.

European Heart Journal|July 2, 2002

Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT TrialW-C Chang, R A Harrington, M L Simoons, et al.

Canadian Journal of Physiology and Pharmacology|February 1, 1991

Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation-contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failureP J O'Brien, H Shen, J Weiler, et al.

Journal of the American College of Cardiology|May 1, 1996

Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)A Langer, S G Goodman, E J Topol, et al.

The Canadian Journal of Cardiology|November 1, 1994

Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study GroupC D Morgan, M Gent, P A Daly, et al.

Journal of the American College of Cardiology|June 1, 1991

Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study GroupC D Morgan, R S Roberts, A Haq, et al.

Archives of Internal Medicine|February 15, 2001

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and SurvivalB M Massie, P W Armstrong, J G Cleland, et al.

Circulation|May 1, 1991

Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentrationG W Moe, E A Grima, C Angus, et al.

Journal of the American College of Cardiology|June 1, 1995

Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesA Langer, M W Krucoff, P Klootwijk, et al.

European Heart Journal|November 10, 2000

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.

Pageof 21

Showing results (131-140 of 210) with videos related to

Sort By:

Pageof 21

The Canadian Journal of Cardiology|September 1, 1992

Reverse redistribution on exercise thallium scintigraphy: relationship to coronary patency and ventricular function after myocardial infarctionA Langer, R J Burns, M R Freeman, et al.

European Heart Journal|July 2, 2002

Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT TrialW-C Chang, R A Harrington, M L Simoons, et al.

Canadian Journal of Physiology and Pharmacology|February 1, 1991

Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation-contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failureP J O'Brien, H Shen, J Weiler, et al.

Journal of the American College of Cardiology|May 1, 1996

Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)A Langer, S G Goodman, E J Topol, et al.

The Canadian Journal of Cardiology|November 1, 1994

Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study GroupC D Morgan, M Gent, P A Daly, et al.

Journal of the American College of Cardiology|June 1, 1991

Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study GroupC D Morgan, R S Roberts, A Haq, et al.

Archives of Internal Medicine|February 15, 2001

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and SurvivalB M Massie, P W Armstrong, J G Cleland, et al.

Circulation|May 1, 1991

Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentrationG W Moe, E A Grima, C Angus, et al.

Journal of the American College of Cardiology|June 1, 1995

Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesA Langer, M W Krucoff, P Klootwijk, et al.

European Heart Journal|November 10, 2000

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.

Pageof 21